Request appointment
177 Fort Washington AveNew York, NY 10032
Fax+1 212-305-1754
Overview of Dr. Zucker
Dr. Jason Zucker is an infectious disease specialist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, NewYork-Presbyterian/Columbia University Irving Medical Center, and NewYork-Presbyterian/Allen Hospital. He received his medical degree from Rutgers New Jersey Medical School and has been in practice 16 years. He is one of 133 doctors at New York-Presbyterian Hospital and one of 52 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Infectious Disease. He has more than 100 publications and over 500 citings.
Education & Training
Rutgers Health/New Jersey Medical SchoolResidency, Internal Medicine/Pediatrics, 2010 - 2014- Rutgers New Jersey Medical SchoolClass of 2010
Certifications & Licensure
NY State Medical License 2015 - 2028
NJ State Medical License 2014 - 2015
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Infectious Diseases
Publications & Presentations
PubMed
- Standard Risk-Based Screening Tools Fail to Reliably Predict STI Acquisition Among Persons Using PrEP in New York City: Implications for Universal STI Screening in PrE...Max Flanagan, Elijah LaSota, Simian Huang, Joshua Klein, Tae Yoon Kim
Sexually Transmitted Diseases. 2026-08-21 - A Randomized Controlled Trial of a Digital Patient Decision Tool to Increase Sexually Transmitted Infection Testing in the Emergency Department.Lauren S Chernick, Talia Adler, Jaciara De Souza, Christina N Franqui, Lisa-Pierre Tchoungui
Annals of Emergency Medicine. 2026-08-01 - Trends in Triple-Site Testing for Chlamydia and Gonorrhea in New York City: A Cross-Sectional Study Using Health Information Exchange Data.Emma Tucker, Harry Reyes Nieva, Delivette Castor, Michael T Yin, Peter Gordon
Sexually Transmitted Diseases. 2026-07-01
Press Mentions
High Viral Load Spikes Placental MalariaJuly 24th, 2025- There’s Finally a New Treatment for Drug-Resistant GonorrheaApril 18th, 2025
- UTI Drug Offers Hope as New Gonorrhoea Treatment – Global StudyApril 15th, 2025
Grant Support
- A Cluster Randomized Stepped-Wedge Effectiveness-Implementation Trial of a Patient Decision Aid to Increase Sexually Transmitted Infection Testing in the Emergency Department: The STIckER TrialCOLUMBIA UNIVERSITY HEALTH SCIENCES2026–2031
- Doxy4STICare - Doxycycline for Sexually Transmitted Infections; A Comprehensive Assessment of Antimicrobial Resistance and EngagementCOLUMBIA UNIVERSITY HEALTH SCIENCES2025–2030
- Doxy4STICare - Doxycycline for Sexually Transmitted Infections; A Comprehensive Assessment of Antimicrobial Resistance and EngagementCOLUMBIA UNIVERSITY HEALTH SCIENCES2024–2025
- A Digital Patient Decision Aid to Increase Sexually Transmitted Infection Testing in the Emergency Department: The STIckER StudyCOLUMBIA UNIVERSITY HEALTH SCIENCES2022–2025
- Harnessing Bioinformatics for HIV Prevention: Understanding Persistence in Comprehensive HIV Prevention ServicesCOLUMBIA UNIVERSITY HEALTH SCIENCES2020–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
